Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54M
-
Number of holders
-
100
-
Total 13F shares, excl. options
-
36.6M
-
Shares change
-
+9.47M
-
Total reported value, excl. options
-
$1.03B
-
Value change
-
+$297M
-
Put/Call ratio
-
1.31
-
Number of buys
-
71
-
Number of sells
-
-24
-
Price
-
$28.21
Significant Holders of Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) as of Q3 2021
117 filings reported holding FULC - Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q3 2021.
Fulcrum Therapeutics, Inc. - Common Stock, par value $0.001 per share (FULC) has 100 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.6M shares
of 54M outstanding shares and own 67.63% of the company stock.
Largest 10 shareholders include FMR LLC (6.04M shares), TRV GP III, LLC (4.96M shares), RTW INVESTMENTS, LP (3.86M shares), TRV GP IV, LLC (2.34M shares), BlackRock Inc. (2.03M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1.94M shares), COWEN AND COMPANY, LLC (1.56M shares), VANGUARD GROUP INC (1.25M shares), BOXER CAPITAL, LLC (1.25M shares), and ADAGE CAPITAL PARTNERS GP, L.L.C. (1.18M shares).
This table shows the top 100 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.